Next, we assessed the expression of HAS2-AS1 in different GBM cell lines (LN18, U251, LNZ308, LN229, SNB19, U87MG) by qRT-PCR (Figure 1D), and U87MG and U251 cells were selected for further experiments. Here, HAS2 is linked to glioblastoma.